Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Esperion Theraptc (NQ: ESPR )

25.93 USD +0.48 (+1.89%)
Official Closing Price Updated: 7:39 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Esperion Theraptc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
NASDAQ:ESPR Shareholder Notice: Lawsuit Alleges Misleading Statements by Esperion Therapeutics, Inc
San Diego, CA -- (SBWIRE) -- 05/22/2018 -- An investor, who purchased shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR), filed a lawsuit over alleged violations of Federal Securities Laws by... 
From SBWire - Latest Press Releases
Kessler Topaz Meltzer & Check, LLP Announces Investor Class Action Lawsuit Filed Against Esperion Therapeutics, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP announces that an investor class action lawsuit has been filed against Esperion Therapeutics, Inc. (Nasdaq: ESPR) (“Esperion”) on behalf of purchasers... 
From Business Wire News Releases
Esperion to Participate in Fireside Chat at the UBS Global Healthcare Conference
Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ESPR
From ACCESSWIRE
ESPR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Michigan on behalf of investors who purchased... 
From GlobeNewswire News Releases
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018
Levi & Korsinsky notifies Esperion shareholders of commencement of a class action. 
From Business Wire News Releases
ESPR REMINDER: Pawar Law Reminds Investors of Important July 6, 2018 Lead Plaintiff Deadline in Class Action– ESPR
From ACCESSWIRE
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 – ESPR
The following statement is being issued by Levi & Korsinsky, LLP: 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR
From ACCESSWIRE
ESPR ALERT: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors of Important July 6 Deadline in Class Action
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Esperion Therapeutics, Inc. (NASDAQ:ESPR) from February 22, 2017 through May 1, 2018, both dates inclusive... 
From Business Wire News Releases
The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Esperion Therapeutics, Inc. (ESPR)
The Klein Law Firm reminds investors of the commencement of an investigation of Esperion Therapeutics, Inc. 
From Business Wire News Releases
DEADLINE ALERT: Shareholder Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. – ESPR
Kaskela Law LLC alerts Esperion Therapeutics, Inc. (NASDAQ:ESPR) (“Esperion” or the “Company”) shareholders that a class action lawsuit has been filed on behalf of purchasers of the Company’s... 
From GlobeNewswire News Releases
The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Esperion Therapeutics, Inc. (ESPR)
The Klein Law Firm announces the commencement of an investigation of Esperion Therapeutics, Inc. 
From Business Wire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR) and Encourages Investors to Contact the Firm
Bragar Eagel & Squire Reminds Investors of Class Action Lawsuit Against Esperion Therapeutics (ESPR) and Encourages Investors to Contact the Firm 
From Business Wire News Releases
INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. -- ESPR
From ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR
From ACCESSWIRE
ESPR INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Esperion Therapeutics, Inc.
The Law Offices of Vincent Wong reminds investors of an investigation concerning Esperion Therapeutics, Inc. 
From Business Wire News Releases
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. - ESPR
From ACCESSWIRE
Kessler Topaz Meltzer & Check, LLP Announces Investor Class Action Filed Against Esperion Therapeutics, Inc. - ESPR
From ACCESSWIRE
ESPR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Esperion Therapeutics, Inc.
The Law Offices of Vincent Wong notifies investors in Esperion of a class action. 
From Business Wire News Releases
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Esperion Therapeutics, Inc.
Federman & Sherwood announces that on May 7, 2018, a class action lawsuit was filed in the United States District Court for the District of Michigan against Esperion Therapeutics, Inc. (NASDAQ:ESPR).... 
From GlobeNewswire News Releases
Important Deadline Notice for Esperion Therapeutics, Inc. Shareholders - ESPR
From ACCESSWIRE
Esperion to Participate in Fireside Chat at the Bank of America Merrill Lynch 2018 Healthcare Conference
Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with... 
From GlobeNewswire News Releases
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Esperion Therapeutics, Inc.
Levi & Korsinsky reminds investors it has commenced an investigation of Esperion Therapeutics, Inc. 
From Business Wire News Releases
Deadline Alert for Esperion Therapeutics, Inc. Shareholders in Class Action Lawsuit - ESPR
From ACCESSWIRE
ESPERION INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Esperion Therapeutics, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Esperion Therapeutics, Inc. (“Esperion” or the “Company”) (NASDAQ:ESPR) of the July 6, 2018 deadline to seek the role... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Esperion Therapeutics, Inc.
Levi & Korsinsky announces it has commenced an investigation of Esperion Therapeutics, Inc. 
From Business Wire News Releases
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR) and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Esperion (ESPR) and Encourages Investors to Contact the Firm 
From Business Wire News Releases
EQUITY ALERT: Rosen Law Announces Filing of Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. – ESPR
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Esperion Therapeutics, Inc. (NASDAQ:ESPR) from February... 
From Business Wire News Releases
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Esperion Therapeutics, Inc. ("Esperion" or the "Company") (NASDAQ: ESPR)... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.